课题基金 / 基金详情

Deciphering the molecular & cellular basis of Low-Grade Glioma

Deciphering the molecular & cellular basis of Low-Grade Glioma
破译分子
批准号：
478958
负责人：
Schramek Daniel
金额：
$76.91万
依托单位：
Sinai Health System (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2028-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=478958&lang=en
关键词：
Crispr-A Screening In Vivo Crispr Screening Low Grade Glioma Singe Cell Transcriptomics

项目摘要

项目成果

Schramek Daniel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Low-grade glioma (LGG) are brain tumors diagnosed in people between 30-45 years of age. At first, they are relatively benign (not harmful) and tend to grow unrecognized over decades to a size that causes headaches and seizures. Unfortunately, almost all l
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying and characterizing essential genes and cancer driver genes in HNSCC using in vivo CRISPR screens.
  • 批准号：
    478950
  • 项目类别：
    Operating Grants
  • 资助金额：
    $77.47万
  • 财政年份：
    2023
  • 负责人：
    Schramek Daniel
  • 依托单位：
    Sinai Health System (Toronto)
Identifying essential genes for epithelial homeostasis and KRas-driven carcinomas using in vivo CRISPR screens.
Deciphering the molecular & cellular basis of aggressive basal-like breast cancer
In vivo CRISPR screen to identify clinically relevant therapeutic targets for lung cancer
海外基金